SCHEMBL480300

SCHEMBL480300

CCCCCCCCCCCCCC(=O)NC([O])CC

nearest known ligand 0.66

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
MAPK1 P28482 1/20 0.66
DNM1 Q05193 1/20 0.58
PLA2G2C Q5R387 1/20 0.57
HSP90AA1 P07900 1/20 0.55
NOD1 Q9Y239 1/20 0.53
PLA2G10 O15496 2/20 0.53
ASAH2 Q9NR71 1/20 0.47
CPT2 P23786 1/20 0.47
CPT1A P50416 1/20 0.47
CPT1B Q92523 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480429 1.00 FAAH (0.66) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL4344183 0.90 FAAH (0.58) FAAHMEN1KMT2AASAH2
SCHEMBL15349438 0.90 FAAH (0.58) FAAHMEN1KMT2AASAH2
SCHEMBL7368816 0.84 FAAH (0.60) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL11171555 0.82 FAAH (0.68) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL12479263 0.82 FAAH (0.68) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL16011206 0.82 FAAH (0.68) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL2058959 0.82 DNM1 (0.70) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL16011319 0.82 FAAH (0.68) FAAHMEN1KMT2AMAPK1DNM1
SCHEMBL2058507 0.82 DNM1 (0.70) FAAHMEN1KMT2AMAPK1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023201321-A1 COMPOSITIONS AND METHODS FOR IMPROVING THERMAL AND BRINE STABILITY OF NANOPARTICLES CHAMPIONX USA INC. (US) 2023-10-19 WO disclosed
EP-4203902-A1 HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION Henkel AG & Co. KGaA (DE) 2023-07-05 EP disclosed
WO-2022042978-A1 EMULSION SHAMPOOS HENKEL AG & CO. KGAA (DE) 2022-03-03 WO disclosed
WO-2022042979-A1 HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION HENKEL AG & CO. KGAA (DE) 2022-03-03 WO disclosed
US-9777407-B2 Hydrophilic polyproylene melt additives 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-10-03 US disclosed
EP-2411061-B1 HYDROPHILIC POLYPROPYLENE MELT ADDITIVES 3M INNOVATIVE PROPERTIES CO (US) 2014-11-19 EP disclosed
WO-2014149363-A1 UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN ISP INVESTMENTS INC. (US) 2014-09-25 WO disclosed
WO-2014149486-A1 POLYMERS POLYMERIZED FROM AT LEAST FOUR MONOMERS, AND COMPOSITIONS AND USES THEREOF ISP INVESTMENTS INC. (US) 2014-09-25 WO disclosed
WO-2014110203-A1 POLYMERS POLYMERIZED FROM AT LEAST FOUR MONOMERS, AND COMPOSITIONS AND USES THEREOF ISP INVESTMENTS INC. (US) 2014-07-17 WO disclosed
US-20120077886-A1 HYDROPHILIC POLYPROYLENE MELT ADDITIVES 3M INNOVATIVE PROPERTIES COMPANY 2012-03-29 US disclosed
EP-2411061-A1 HYDROPHILIC POLYPROPYLENE MELT ADDITIVES 3M Innovative Properties Company (US) 2012-02-01 EP disclosed
WO-2010111491-A1 HYDROPHILIC POLYPROPYLENE MELT ADDITIVES 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-09-30 WO disclosed
US-5407536-A Amphoteric surfactants as glass fiber dispersants for the manufacture of uniform glass fiber mats RHONE-POULENC INC. (US) 1995-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077886-A1 HYDROPHILIC POLYPROYLENE MELT ADDITIVES HSPH1, MSH2, HSPBP1 FAAH 4449/4885MEN1 2058/4885KMT2A 2534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.